Introduction
Diabetic neuropathy is the most common chronic complication of diabetes
mellitus (DM), affecting different parts of the nervous system, causing
different clinical findings related to the peripheral and / or autonomic
nervous system, and is associated with the duration and degree of
glycemic control (1,2). Neuropathy causes significant morbidity such as
pain, loss of sensation, foot ulcer, gangrene and amputation (2).
According to the study of the TURNEP working group in our country,
diabetic peripheral neuropathy determined by clinical examination
affects 40.4% of diabetic patients (3). If clinical examination and
electrophysiological examination method are added, this rate has been
shown to increase to 62.2% (3).
While it is one of the late findings of Type 1 DM, it can be seen in
Type 2 DM patients in the early period, even in the prediabetes period
(4). Since the clinical findings of diabetic neuropathy are